Bayer Operating Income 2010-2024 | BAYRY

Bayer operating income for the twelve months ending September 30, 2024 was $0.550B, a 212.43% decline year-over-year.

  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.
  • Bayer annual operating income for 2022 was $7.388B, a 86.24% increase from 2021.
  • Bayer annual operating income for 2021 was $3.967B, a 121.48% decline from 2020.

Bayer Operating Income 2010-2024 | BAYRY

  • Bayer annual operating income for 2023 was $0.662B, a 91.03% decline from 2022.
  • Bayer annual operating income for 2022 was $7.388B, a 86.24% increase from 2021.
  • Bayer annual operating income for 2021 was $3.967B, a 121.48% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B